Clinical trial
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
NCT01587651 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- February 28, 2013
- Enrollment
- 110 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.